Effect of Ankaferd Blood Stopper on air leakage in the lung and prevention of bleeding: an experimental study by Kılıçgün, Ali et al.
RESEARCH ARTICLE Open Access
Effect of Ankaferd Blood Stopper on air leakage
in the lung and prevention of bleeding:
an experimental study
Ali Kılıçgün
1*, Necla G Sarıkaş
2, Tanzer Korkmaz
3, Özkan Saydam
4, Çetin Boran
5, Güledal Boztaş
6
Abstract
Background: Air leakage and hemorrhage are important causes of morbidity and mortality in operations and
traumas of the lung. Ankaferd Blood Stopper is a herbal product used for stopping hemorrhage. In our study, we
investigated the efficacy of Ankaferd Blood Stopper in the prevention of air leakage in the lung and bleeding.
Methods: A total of twenty-one Wistar-Albino rats weighing 240 ± 20 grams were used in our study. An equal
amount of injury was created in all groups by performing left thoracotomies. No interventions were made on
tissue injury in the first group, and suturing was performed in the second group, and Ankaferd was applied in the
third group. Air leakage and duration of bleeding were recorded in all groups.
Results: A statistically significant difference was found between the three groups in terms of air leakage time
(p = 0,0001) and bleeding time (p = 0,0001). While a significant effect of Ankaferd was detected in terms of air
leakage compared to standard surgery (p = 0,017), no difference was found in terms of bleeding time.
Conclusions: Ankaferd Blood Stopper ceases the air leakage in the lung parenchyma significantly and effectively.
No significant difference is seen compared to the standard surgery group, although it ceases bleeding significantly.
Introduction
Prolongation of air leakage and bleeding after lung
operations are among the important causes of morbid-
ity. Prolongation of air leakage is the second leading
cause of delay in the time of discharge from the hospital
[1]. Prolonged parenchymal air leakage is commonly
seen after lung resections and has been reported at a
rate of 15-18%. Thus, chest tubes are needed for a
longer time and consequently, this causes pain,
decreased mobility and possible complications [2]. The
standard method for prevention of air leakage and
bleeding developing following lung resection is surgical
suturing or stapler application. Tissue adhesives and
supported stapler use are the other methods [3-10].
Ankaferd Blood Stopper (ABS) is a herbal product
used as a hemostatic agent in traditional Turkish medi-
cine. It is a topical agent, the safety and efficacy of
which have been proven in dermal, external traumatic,
postoperative and dental bleedings [8]. Clinical and
experimental studies on its blood stopping effect are
available. Its effect on stopping bleeding and preventing
air leakage in the lungs is not known. In this study, we
experimentally investigated the effect of Ankaferd Blood
Stopper on stopping bleeding and preventing air leakage
in the lungs.
Methods
This study was carried out in the animal experiment
laboratory of our institution. All rats were treated in a
humane manner according to the Guide for the Care
and Use of Laboratory Animals. The study was com-
menced after having obtained approval from the ethical
committee for experimental animals.
A total of 21 adult male Wistar Albino rats weighing
240 ± 20 grams were used in our study. Three groups
were constituted with seven rats in each. An equal extent
of injury was created in all groups by performing left
thoracotomies. No interventions were made on the tissue
injury in the first group (control group), suturing was
performed in the second group (standard surgery group),
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group (Ankaferd group). Air leakage and duration of
bleeding were recorded in all groups. The rats were sacri-
ficed after the procedure had been completed and histo-
pathological assessment was performed.
Anesthesia Technique
General anesthesia was applied on all test subjects.
A combination of 60 mg/kg ketamin hydrochloride
(Ketalar, Parke Davis-Eczacıbası, İstanbul, Turkey) and
10 mg/kg xylacine hydrochloride (Rompun, Bayer, Tor-
onto, Canada) were used as anesthetic agents. The rats
were fixed in the supine position. The operation sites
were cleaned and sterilization was provided. Tracheo-
tomies were performed with neck incisions and intuba-
tion was performed.
Surgical Technique
All the rats underwent left anterior thoracotomy. An
injury 5 mm in length and 2mm in depth was created in
the left lung parenchyma using a scalpel. In the control
group (Group I), no interventions were made for par-
enchymal injury and a compress was applied and conti-
nuation of the air leakage and bleeding was monitored
every 5 seconds. These durations were recorded. The
procedure was terminated at the 100. second. In the
standard surgery group (Group II), after having created
an equal injury, the injury was sutured using 6-0 poly-
glactin (vicryl). Then the air leakage and bleeding were
controlled and the times of cessation of the leakage and
bleeding were recorded. In the Ankaferd group (Group
III), a spray form of the Ankaferd Blood Stopper was
applied 4 times onto the identical injury. It was con-
trolled at every 5 seconds and cessation times of the air
leakage and bleeding were recorded.
Statistical Analysis
All statistical analyses and calculations were performed
using the SPSS for Windows Version 16.0 (SPSS Inc,
Chicogo, IL, USA) package program. The Kruskal Wallis
test was used to find whether or not there was a differ-
ence between the three groups in terms of air leakage
time and bleeding time. Paired assessments were made
using the Mann Whitney U test to find the group where
the difference originated from. The level of significance
was set at p < 0.05.
Histopathological Analysis
Some of the rats (n = 11) were sacrificed intraopera-
tively after the procedure had been completed and the
specimens were obtained from the lung. The remaining
rats (n = 10) were sacrificed after monitorization for five
days and the lung was analyzed patologically on the fifth
day. The sampled lung tissue was fixed with formalin
solution (10%). Paraffin cross sections were obtained
after routine follow-up and analyzed after staining with
hematoxylin-eosin.
Results
While the mean air leakage time was 95.7 ± 6.07 sec, the
bleeding time was measured as 75.00 ± 15.00 sec in the
control group. While the mean time of air leakage was
27.14 ± 21.76 sec, the bleeding time was measured as
9.28 ± 7.31 sec in the standard surgery group, whereas
both the air leakage time and the bleeding time were
measured as 7.14 ± 2.68 sec in the Ankaferd group
(Table 1) (Figure 1). Bleeding and air leakage were found
to have stopped in the shortest mean duration in the
Ankaferd group.
A statistically significant difference was found between
the three groups in terms of duration of air leakage (p =
0,0001) and bleeding (p = 0,001). There was a statisti-
cally significant difference between the control group
and the standard surgery group in terms of duration of
leakage (p = 0,002) and bleeding time (p = 0,001). A sta-
tistically significant difference was found between the
standard surgery group and the Ankaferd group in
terms of air leakage (p = 0,017). No statistically signifi-
cant difference was found between the standard surgery
group and the Ankaferd group in terms of bleeding time
(p = 0,827). A statistically significant difference was
detected between the control group and the Ankaferd
group in terms of air leakage time (p = 0,001) and
bleeding time (p = 0,001).
Normal lung regions (Figure 2) and the lungs of rats
sacrificed intraoperatively and on the fifth day were ana-
lyzed in the histopathological evaluation. Masses of
hemolyzed clot (blood-fibrin masses) were observed in
the areas in which Ankaferd had been applied in the
lungs of intraoperatively sacrificed rats (Figure 3). Newly
organized fibrin plugs were observed in the alveoli of
the lungs of rats that had been sacrificed on the fifth, in
which Ankaferd had been applied (Figure 4).
Discussion
The incidence of leakage from the lung parenchyma is
still vey high despite the use of many surgical techni-
ques and biological agents to reduce it. Leakage is
Table 1 Mean air leakage and bleeding times of the
groups
Groups Mean air leakage
time (sec)
Mean bleeding
time (sec)
Group I (control group) 95.7 ± 6.07 75.00 ± 15.00
Group II (standard
surgery group)
27.14 ± 21.76 9.28 ± 7.31
Group III (Ankaferd
group)
7.14 ± 2.67 7.14 ± 2.68
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tively, and the rate of air leakages continuing for longer
than the 7. postoperative day is between 15% and 18%.
The ideal method for preventing this has yet not been
determined [2].
Prolongation of air leakage is the second leading cause
of delay in the time of discharge from the hospital fol-
lowing pain [1]. Prolongation of air leakage following
lung resections is among the important causes of mor-
bidity. It is the second leading complication following
arrhythmias. Cause of morbidity is air leakage exceeding
five days after segmentectomy (5.9%), lobectomy (9.6%)
and pneumectomy (0.4%) [11]. In the study of Varela et
al. [12] air leakage exceeding five days was found to be
related to significant pulmonary complications and
atelectasis, pneumonia, and empyema.
Air lekage is a common condition seen after lung
operations. The standard method for prevention of air
leakages developing following lung operations is surgical
suturing or stapler application. The other methods are
fibrin glue, synthetic polyethylene glucose-based hydro-
gel adhesives, tachocomb, covered adhesives or stapler
use supported with various materials [3-10].
Fibrin glue application is a commonly used approach.
There are different opinions about the utilization of
fibrin glue. In the prospective study carried out by
Fabian et al. [4] fibrin glue was applied to one group in
100 lung resections. Both groups were compared in
terms of air leakage, amount of pleural drainage, time of
chest tube removal and duration of hospitalization.
Figure 1 Distribution of air leakage and bleeding times in the
control group (Group 1, n = 7), standard surgery group (Group
2, n = 7) and Ankaferd Blood Stopper group (Group 3, n = 7).
Figure 2 Appearance of lung tissue of the normal rats ( H&E,
X200).
Figure 3 Changes in the early period (intraoperative) in the
lung in which Ankaferd was applied. Hemolyzed clot masses
(blood-fibrin masses) are observed in the areas exposed to Ankaferd
( H&E, X200).
Figure 4 Histopathological changes on the 5. day in the lung
in which Ankaferd was applied. Newly organized fibrin plugs are
observed in the alveoli of the lung of Ankaferd-applied rats( H&E,
X200).
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decrease the incidence of air leakage, the air leakage ces-
sation time, chest tube removal time, and the rate of
prolonged air leakage. No difference was found in terms
of the amount of chest tube drainage and duration of
hospitalization. No complications related to fibrin glue
were found. In conclusion, fibrin glue utilization was
reported to be effective and safe. In a study carried out
with fibrin glue comprising 360 patients, it was shown
to decrease only the chest tube removal time and not to
affect the prolongation of air leakage (>7 days) and
duration of hospitalization [5].
Ankaferd Blood Stopper (ABS) is a herbal product
used as a hemostatic agent. It contains a standardized
mixture of Thymus vulgaris, Glycyrrhiza glabra, Vitis
vinifera, Alpinia officinarum and Urtica dioica. All of
these plants are effective on the endothelium, blood
cells, angiogenesis, cellular proliferation, vascular
dynamics and mediators. The mechanism of action of
this drug which is being used clinically and found to be
safe is not fully understood [13]. There have been no
studies investigating the effect of Ankaferd Blood Stop-
per on air leakage in the lung. In our study, we investi-
gated the air leakage repressive effect of ABS. It
prevents air leakage significantly compared to the con-
trol group and the standard surgery group.
Postoperative hemorrhage is among the important
causes of morbidity in thoracic surgery practice. The
incidence of at least 4 units of blood transfusion
requirement after lung resections is 2.9% in lobectomy,
3% in pneumonectomy [11]. The focus of hemorrhage
cannot be determined in most of the cases. In the study
of Sirbu et al. analyzing 1960 patients who underwent
thoracotomy, they detected that the most common
cause of re-thoracotomy was bleeding (52%). In this
study, while the source of bleeding was found to be
mediastinal and bronchial vessels (23%), intercostal ves-
sels (17%) or pulmonary vessels (17%), no sources of
bleeding could be detected in most of the cases (41%)
[14].
The blood stopping effect of Ankaferd Blood Stopper
has been demonstrated in many clinical and experimen-
tal studies. It was found to be successful in the treat-
ment of rectal ulcers in the study of Ibis et al. [15]
which was carried out in gastrointestinal hemorrhages.
It was shown to reduce hemorrhage considerably in
bladder hemorrhages and partial nephrectomies [16].
Ankaferd Blood Stopper was shown to decrease the
operation time and warm ischemia time in the partial
nephrectomy model in rats. In the pathological anaysis,
erythrocyte aggregation was found to develop, but glo-
merular necrosis and calcifications were not observed
[16]. ABS was reported to reduce hemorrhage effectively
in the study on its clinical use in tonsillectomies [17]. It
was emphasized that it could be beneficial clinically
when used endoscopically in gastrointestinal hemor-
rhages related to tumor [18]. Similarly, it was stated to
be effective in hemorrhages related to endobronchial
tumor when used endoscopically [19].
In our study, when we evaluated the blood stopping
effect of ABS, we found that this property was promi-
nent compared to the control group; however, there was
no statistically significant difference compared to the
standard surgery group. Ankaferd Blood Stopper pre-
vents air leakage in the lung effectively. It has an effect
on stopping bleeding, but the effect is similar to that in
standard surgery. Further experimental and clinical stu-
dies are needed to investigate the effect of this plant
extract in the lung.
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